Ameliorative effect of apelin on streptozotocin-induced diabetes and its associated cardiac hypertrophy
Aim: Apelin, an adipocyte-derived factor, exhibited a number of cardioprotective properties; however, its effect in diabetes which is a major risk factor for cardiovascular disease (CVD) needs to be further studied. So this work was designed to evaluate the effect of apelin on diabetes and its assoc...
Main Author: | Islam Ibrahim Hegab |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-06-01
|
Series: | Alexandria Journal of Medicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2090506816301518 |
Similar Items
-
Atorvastatin attenuates arterial stiffness and cardiac hypertrophy in streptozotocin-induced diabetic rats
by: Ru-Wen Chang, et al.
Published: (2012) -
Pyridoxamine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats
by: Pei-Shan Tsai, et al.
Published: (2008) -
Acetyl-l-carnitine attenuates arterial stiffness and cardiac hypertrophy in streptozotocin-induced diabetic rats
by: Ya-Wei Tseng, et al.
Published: (2009) -
Catechin Treatment Ameliorates Diabetes and Its Complications in Streptozotocin-Induced Diabetic Rats
by: Saeed Samarghandian, et al.
Published: (2017-02-01) -
Stretch-Induced Biased Signaling in Angiotensin II Type 1 and Apelin Receptors for the Mediation of Cardiac Contractility and Hypertrophy
by: Kinya Seo, et al.
Published: (2020-03-01)